Breaking News
Get 40% Off 0
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance Find Stocks Now
Close

Recipharm publ AB (12R)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
Recipharm publ AB historical data, for real-time data please try another search
14.910 +0.080    +0.54%
- Delayed Data. Currency in EUR ( Disclaimer )
Type:  Equity
Market:  Germany
ISIN:  SE0005757267 
S/N:  A111D5
  • Volume: 0
  • Bid/Ask: 11.660 / 11.810
  • Day's Range: 14.670 - 14.940
Recipharm publ AB 14.910 +0.080 +0.54%

12R Overview

 
"Recipharm publ AB stock price live, this page displays ST RECIb stock exchange data. View the RECIb premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Recipharm publ AB real time stock price chart below.

What Is the Recipharm publ AB Stock Price Today?
The Recipharm publ AB stock price today is 14.910.

What Is the Stock Symbol for Recipharm publ AB?
The stock symbol for Recipharm publ AB is ""RECIb.""

What Stock Exchange Does Recipharm publ AB Trade On?
Recipharm publ AB is listed and trades on the Stockholm stock exchange.

Is Recipharm publ AB a Good Stock to Buy?
Determining whether Recipharm publ AB—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.

You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the RECIb quote. (ISIN: SE0005757267)"
Loading
Last Update:
  • 1 Day
  • 1 Week
  • 1 Month
  • 3 Months
  • 6 Months
  • 1 Year
  • 5 years
  • Max
Prev. Close14.83
Day's Range14.67 - 14.94
Revenue5.39B
Open14.84
52 wk Range14.67 - 14.94
EPSN/A
VolumeN/A
Market Cap1.52B
Dividend (Yield)0.12 (1.06%)
Average Volume (3m)300
P/E RatioN/A
BetaN/A
1-Year Change0%
Shares OutstandingN/A
Next Earnings DateN/A
What is your sentiment on Recipharm publ AB?
or
Vote to see community's results!

Recipharm publ AB Analysis


Technical Summary

Type Daily Weekly Monthly
Moving Averages Buy Buy Buy
Technical Indicators Strong Buy Strong Buy Strong Buy
Summary Strong Buy Strong Buy Strong Buy

Trending Stocks

Create Alert
Add to Watchlist
Add to/Remove from a Portfolio  
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

  Name Last High Low Chg. Chg. % Vol. Time
  DMCI 10.940 11.000 10.700 +0.260 +2.43% 2.36M  
  Semirara Mining 32.25 32.25 31.60 +0.10 +0.31% 1.22M  
  Keppel Philippines 16.860 16.980 16.140 +0.740 +4.59% 4.04M  
  Jollibee Foods 235.00 236.80 228.80 +3.00 +1.29% 476.73K  
  LT Group 9.710 9.790 9.670 +0.040 +0.41% 578.90K  
  Converge Information Communications Technology Sol 8.98 9.10 8.90 -0.06 -0.66% 571.20K  
  GMA Network 7.740 7.770 7.640 -0.030 -0.39% 588.40K  
  Ayala Land 28.450 28.850 28.000 0.000 0.00% 10.84M 14:56:00  
  Ayala 595.00 608.00 595.00 -4.00 -0.67% 62.85K  
  Rockwell Land 1.440 1.440 1.430 -0.010 -0.69% 14.00K  

Recipharm publ AB Company Profile

IndustryPharmaceuticals
SectorHealthcare
Employees

-

Equity Type

ORD

Recipharm AB (publ) operates as a pharmaceutical contract development and manufacturing company in Sweden, the United Kingdom, Italy, Germany, France, India, Spain, Portugal, and internationally. It operates through four segments: Advanced Delivery Systems (ADS), Manufacturing Steriles (MFG-S), Manufacturing Solids & Others (MFG-SO), and Development & Licensing (D&L). The ADS segment develops and manufactures inhalation products and devices, including integrated drug solutions, medical check valves, and injection devices. The MFG-S segment manufactures sterile products using lyophilisation and blow-fillseal technologies. The MFG-SO segment manufactures non-sterile products, such as tablets, capsules, semi-solids, liquids, and powders. The D&L segment provides pharmaceutical development services, including preclinical and formulation development, and clinical trial material services; manages patents, technologies, and drug product rights; and develops and manufactures drug substance. It also offers packaging products comprising bottles, blisters, stick-packs, vials, ampoules, syringes, pouches, and patches; and online vendor managed inventory solutions. The company was founded in 1994 and is headquartered in Stockholm, Sweden.

Read More
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

RECIb Comments

Write your thoughts about Recipharm publ
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email